医脉通(02192)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02192 医脉通

已收盘 09-22 16:08:13

6.975

+0.000

0.00%

最高7.050	最低6.970	成交量92.75万
今开6.950	昨收6.975	日振幅1.15%
总市值51.62亿	流通市值51.62亿	总股本7.40亿
成交额648.82万	换手率0.13%	流通股本7.40亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02192","market":"HK","secType":"STK","nameCN":"医脉通","latestPrice":6.975,"timestamp":1790064493003,"preClose":6.975,"halted":0,"volume":927500,"delay":0,"changeRate":0,"floatShares":740000000,"shares":740000000,"eps":0.5311168423529411,"marketStatus":"已收盘","change":0,"latestTime":"09-22 16:08:13","open":6.95,"high":7.05,"low":6.97,"amount":6488190,"amplitude":0.01147,"askPrice":7,"askSize":4000,"bidPrice":6.975,"bidSize":6500,"shortable":3,"etf":0,"ttmEps":0.5413716809882352,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790127000000},"marketStatusCode":5,"adr":0,"listingDate":1626278400000,"exchange":"SEHK","adjPreClose":6.975,"dividendRate":0.045004,"openAndCloseTimeList":[[1790040600000,1790049600000],[1790053200000,1790064000000]],"volumeRatio":0.894321,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02192/tweets","defaultTab":"tweets","newsList":[{"id":"1193298857","title":"医脉通2026年中期财报：营收3.15亿元，经调整净利润1.71亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193298857","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193298857?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:53","pubTimestamp":1789721584,"startTime":"0","endTime":"0","summary":"医脉通公布2026年中期业绩，营收3.15亿元，同比增长1.0%。经调整净利润1.71亿元，同比增长2.4%。公告显示，报告期内毛利率为61.6%，比上年同期提升2.6个百分点。经营活动现金流净额达68.0百万元，同比小幅增长约2%。医脉通的医学知识解决方案收入0.09亿元，保持稳定，为境内医师提供在线持续医学教育及临床决策支持，并以自研大模型完善医学指南、文献、用药参考等核心内容。智能患者管理解决方案收入0.10亿元，同比增长0.4%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"医脉通2026年中期财报：营收3.15亿元，经调整净利润1.71亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988580","title":"FIDELITY FUNDS增持医脉通(02192)101.7万股 每股作价约6.81港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988580","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667988580?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:46","pubTimestamp":1789559196,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，9月11日，FIDELITY FUNDS增持医脉通(02192)101.7万股，每股作价6.8107港元，总金额约为692.65万港元。增持后最新持股数目约为3768.38万股，最新持股比例为5.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","LU1235295612.USD","02192","LU1046422090.SGD","BK1587","LU0049112450.USD","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143578228","title":"医脉通：FIDELITY FUNDS增持，好仓比例升至5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143578228","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143578228?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:19","pubTimestamp":1789550360,"startTime":"0","endTime":"0","summary":"FIDELITY FUNDS于2026年9月11日在联交所场内以每股均价6.8107港元买入医脉通股份101.70万股，涉资约692.65万港元，属场内主动交易，即在二级市场直接买卖股份。FIDELITY FUNDS此次增持前持有医脉通好仓3666.68万股，占比4.95%；增持后持股量为3768.38万股，好仓比例升至5.09%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188711000","title":"医脉通：Pandanus Partners L.P.增持，好仓比例升至9.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188711000","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188711000?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:41","pubTimestamp":1788774092,"startTime":"0","endTime":"0","summary":"Pandanus Partners L.P.于2026年9月2日以每股均价7.4323港元买入医脉通股份50.90万股，涉资约378.30万港元。Pandanus Partners L.P.此次增持前持有医脉通好仓6650.36万股，占比8.98%；增持后持股量为6701.26万股，好仓比例升至9.05%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129391036","title":"医脉通：FIL Limited增持，好仓比例升至9.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129391036","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129391036?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:15","pubTimestamp":1788772526,"startTime":"0","endTime":"0","summary":"FIL Limited于2026年9月2日以每股均价7.4323港元买入医脉通股份50.90万股，涉资约378.30万港元。FIL Limited此次增持前持有医脉通好仓6650.36万股，占比8.98%；增持后持股量为6701.26万股，好仓比例升至9.05%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146247786","title":"医脉通：Pandanus Associates Inc.增持，好仓比例升至9.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146247786","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146247786?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:14","pubTimestamp":1788772482,"startTime":"0","endTime":"0","summary":"Pandanus Associates Inc.于2026年9月2日以每股均价7.4323港元买入医脉通股份50.90万股，涉资约378.30万港元。Pandanus Associates Inc.此次增持前持有医脉通好仓6650.36万股，占比8.98%；增持后持股量为6701.26万股，好仓比例升至9.05%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108256135","title":"医脉通8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1108256135","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108256135?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:21","pubTimestamp":1788427285,"startTime":"0","endTime":"0","summary":"医脉通科技有限公司于2026年9月3日披露截至2026年8月31日的证券变动月报表。报告显示，医脉通在8月期间已发行及库藏股份总数未发生增加或减少，截至本月底已发行股份总数依旧为740,274,500股，库藏股份数为0股。根据公告，医脉通的法定注册股本为500,000美元，共计50,000,000,000股普通股，每股面值为0.00001美元，于月末较上月底无变化。截至本月底，公司股本结构整体保持稳定，无股份增发、回购及注销。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664823410","title":"医脉通（02192）续跌近6% 中金指上半年项目价格及执行节奏或存在波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2664823410","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664823410?lang=zh_cn&edition=full","pubTime":"2026-09-03 10:49","pubTimestamp":1788403794,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医脉通 早盘股价受压下行，并跌至近2个月低位，日线图已现3连阴，最新报6.97港元，跌5.81%，成交额895.9万港元。中金公司表示，公司上半年业绩弱于预期，主要因收入端因项目执行节奏波动及利息收入收窄。1H26期间，公司精准营销业务服务医疗客户217家，服务药械产品509个，该机构测算平均单客户及单产品贡献收入产出同比有所下滑，该机构认为公司对医疗客户及产品的前端扩张覆盖仍持续拓展，但项目价格及执行节奏或存在波动。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990517","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1235295612.USD","02192","LU1046422090.SGD","LU0049112450.USD","BK1587","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662063197","title":"医脉通(02192)公布中期业绩 母公司拥有人应占溢利约1.62亿元 同比增长4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662063197","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662063197?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:18","pubTimestamp":1787908728,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医脉通(02192)公布2026年中期业绩，收益约3.15亿元，同比增长1%;母公司拥有人应占溢利约1.62亿元，同比增长4%。经调整净溢利约1.71亿元，同比增长2.4%。基本每股盈利21.87分。公告称，收入增长主要是由于精准营销及企业解决方案收益增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1046422090.SGD","BK1587","LU0049112450.USD","02192","LU1235295612.USD","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171205180","title":"医脉通2026年中期营收3.15亿元，经调整净利润1.71亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171205180","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171205180?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:52","pubTimestamp":1787907141,"startTime":"0","endTime":"0","summary":"医脉通披露2026年上半年财务数据显示，营收约为人民币3.15亿元，同比增幅1.0%。经调整净利润为人民币1.71亿元，同比提升2.4%。公告提到，公司的销售成本约为人民币1.21亿元，同比减少5.5%，主要由于企业大力采用AI工具提升项目交付效率；毛利约为人民币1.94亿元，同比上升5.5%，毛利率达61.6%，相较上年同期上升2.6个百分点。销售及分销开支约人民币2027.2万元，同比增长13.4%；行政开支约0.82亿元，同比下降12.5%；报告期内，公司在研发上投入约3185.9万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"医脉通2026年中期营收3.15亿元，经调整净利润1.71亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660503482","title":"FIL Limited增持医脉通(02192)47.4万股 每股作价约7.92港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660503482","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660503482?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:28","pubTimestamp":1786966085,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，8月12日，FIL Limited增持医脉通(02192)47.4万股，每股作价7.915港元，总金额约为375.17万港元。增持后最新持股数目约为5932.66万股，持股比例为8.01%。本交易涉及关联方：Pandanus Associates Inc.、Pandanus Partners L.P.。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1189","02192","EWH","LU1235295612.USD","LU1046422090.SGD","LU0049112450.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160066428","title":"医脉通：Pandanus Partners L.P.增持，好仓比例升至8.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160066428","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160066428?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:13","pubTimestamp":1786957999,"startTime":"0","endTime":"0","summary":"Pandanus Partners L.P.于2026年8月12日以每股均价7.9150港元买入医脉通股份47.40万股，涉资约375.17万港元。Pandanus Partners L.P.此次增持前持有医脉通好仓5885.26万股，占比7.95%；增持后持股量为5932.66万股，好仓比例升至8.01%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177571804","title":"医脉通：FIL Limited增持，好仓比例升至8.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177571804","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177571804?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:13","pubTimestamp":1786957989,"startTime":"0","endTime":"0","summary":"FIL Limited于2026年8月12日以每股均价7.915港元买入医脉通股份47.40万股，涉资约375.17万港元。FIL Limited此次增持前持有医脉通好仓5885.26万股，占比7.95%；增持后持股量为5932.66万股，好仓比例升至8.01%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167564703","title":"医脉通：Pandanus Associates Inc.增持，好仓比例升至8.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167564703","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167564703?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:11","pubTimestamp":1786957875,"startTime":"0","endTime":"0","summary":"Pandanus Associates Inc.于2026年8月12日以每股均价7.915港元买入医脉通（02192）股份47.40万股，涉资约375.17万港元。Pandanus Associates Inc.此次增持前持有医脉通好仓5885.26万股，占比7.95%；增持后持股量为5932.66万股，好仓比例升至8.01%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116327888","title":"医脉通（02192）将于8月28日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1116327888","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116327888?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:36","pubTimestamp":1786437399,"startTime":"0","endTime":"0","summary":"医脉通科技有限公司（02192）8月11日公告，董事会会议定于2026年8月28日（星期五）举行。会议议程包括：  \n1. 审议并批准截至2026年6月30日止六个月的中期业绩；  \n2. 研究派发中期股息（如有）。\n公司董事会目前由9名董事组成，其中执行董事4名、非执行董事2名、独立非执行董事3名。公告称，相关业绩及股息决定将在董事会会议后及时公布。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154433144","title":"医脉通7月股份变动月报表：股本小幅增加160,375股","url":"https://stock-news.laohu8.com/highlight/detail?id=1154433144","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154433144?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:16","pubTimestamp":1785835004,"startTime":"0","endTime":"0","summary":"医脉通科技有限公司2026年8月4日发布截至2026年7月31日的月度证券变动报告。据公告，公司的法定注册股本维持在50,000,000,000股，每股面值0.00001美元，对应注册股本规模约50万美元，本月未发生变动。根据公告，本月新增发行主要源于公司首次公开发售前购股权计划的行权，行权对应新增发行普通股160,375股，共募集资金约人民币6.09万元。公司剩余的首次公开发售后购股权计划尚可发行或转让的股份数量为69,017,600股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653081663","title":"FIL Limited增持医脉通(02192.HK)130.15万股 每股作价约7.57港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653081663","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653081663?lang=zh_cn&edition=full","pubTime":"2026-07-24 19:30","pubTimestamp":1784892648,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0049112450.USD","BK1587","LU1235295612.USD","BK1189","LU1046422090.SGD","02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153982153","title":"医脉通6月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1153982153","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153982153?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:46","pubTimestamp":1782981971,"startTime":"0","endTime":"0","summary":"2026年7月2日，医脉通发布2026年6月股份变动月报表。报告期为2026年6月1日至6月30日。截至报告期末，公司已发行股份总数为740,114,125股，与上月底保持一致，库藏股份数量为0股，公司股本结构稳定。在股权激励方面，医脉通现有两项购股权计划。于2021年3月29日采纳的首次公开发售前购股权计划在6月期初和期末的购股权数量均为160,375份，截至本月未行使期权发行新股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140103679","title":"医脉通5月股份变动月报表更新，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1140103679","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140103679?lang=zh_cn&edition=full","pubTime":"2026-06-03 18:12","pubTimestamp":1780481526,"startTime":"0","endTime":"0","summary":"医脉通于2026年6月3日披露了2026年5月31日止月份的证券变动月报表。根据公告，医脉通在本报告期内未新增发行股份，也无购回或注销活动，公司股本持续保持稳定。月报披露的首发前及首发后股份期权计划方面，截至5月底，首发前购股权计划项下的股份期权数量合计160,375份，与上月末持平，未有新股发行。首发后购股权计划尚未有新增授出、行使或失效变动，潜在可发行的最大股份数为69,017,600股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635943788","title":"格隆汇个股放量排行榜 | 5月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635943788","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635943788?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:30","pubTimestamp":1778664605,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日腾讯音乐-SW(01698)、阳光保险(06963)、上海电气(02727)、轻松健康(02661)、弘毅文化集团(00419)、FIT HON TENG(06088)、京城机电股份(00187)、北方矿业(00433)、心玮医疗-B(06609)、同源康医药-B(02410)、富通科技(00465)、京东物流(02618)、云顶新耀(01952)、赛晶科技(005","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/13173057083788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01548","02618","02256","03700","03888","00772","01951","00909","06186","00762","01440","06609","01833","03692","06963","06160","01024","01905","02252","02285","02276","06049","09992","00719","02158","02172","06660","01060","02192","01783","00169","81024","02126","09626","02171","06060","02096","02013","09699","02197","01357","06969","09858","02306","09888","06996","00013","09688","01952","00136"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0777},{"period":"3month","weight":0.0721},{"period":"6month","weight":-0.0848},{"period":"1year","weight":-0.4442},{"period":"ytd","weight":-0.2499}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":-0.0372},{"period":"3month","weight":0.0731},{"period":"6month","weight":-0.0116},{"period":"1year","weight":-0.0566},{"period":"ytd","weight":-0.0229}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医脉通科技有限公司是一家主要从事提供精准营销及企业解决方案、医学知识解决方案及智能患者管理解决方案的投资控股公司。精准营销解决方案提供数字推送、数字营销咨询、数字内容创建服务。企业解决方案提供数字市场研究、电子数据采集（EDC）、及临床数据管理系统（CDMS）解决方案、真实世界研究（RWS）支持解决方案等服务。医学知识解决方案提供涵盖持续医学教育及临床决策支持的专业医学信息。智能患者管理解决方案提供患者教育服务（包括内容开发、应用软件开发及其他相关服务）。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.121003},{"month":2,"riseRate":0.4,"avgChangeRate":0.055819},{"month":3,"riseRate":0.6,"avgChangeRate":-0.029734},{"month":4,"riseRate":0.6,"avgChangeRate":0.004142},{"month":5,"riseRate":0.2,"avgChangeRate":-0.080359},{"month":6,"riseRate":0.6,"avgChangeRate":0.077109},{"month":7,"riseRate":0.6,"avgChangeRate":0.011014},{"month":8,"riseRate":0.666667,"avgChangeRate":0.054593},{"month":9,"riseRate":0.5,"avgChangeRate":0.000195},{"month":10,"riseRate":0.2,"avgChangeRate":-0.089996},{"month":11,"riseRate":0.6,"avgChangeRate":0.163486},{"month":12,"riseRate":0.2,"avgChangeRate":-0.12232}],"exchange":"SEHK","name":"医脉通","nameEN":"MEDLIVE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医脉通(02192)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医脉通(02192)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医脉通,02192,医脉通股票,医脉通股票老虎,医脉通股票老虎国际,医脉通行情,医脉通股票行情,医脉通股价,医脉通股市,医脉通股票价格,医脉通股票交易,医脉通股票购买,医脉通股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医脉通(02192)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医脉通(02192)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}